| PARP10 suppresses tumor metastasis through regulation of Aurora A activity Y Zhao, X Hu, L Wei, D Song, J Wang, L You, H Saiyin, Z Li, W Yu, L Yu, ... Oncogene 37 (22), 2921-2935, 2018 | 49 | 2018 |
| CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis X Hu, Y Zhao, L Wei, B Zhu, D Song, J Wang, L Yu, J Wu Oncogene 36 (28), 4047-4059, 2017 | 47 | 2017 |
| Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer X Hu, ES Villodre, R Larson, OM Rahal, X Wang, Y Gong, J Song, ... Communications biology 4 (1), 72, 2021 | 38 | 2021 |
| The expression of APE1 in triple-negative breast cancer and its effect on drug sensitivity of olaparib T Chen, C Liu, H Lu, M Yin, C Shao, X Hu, J Wu, Y Wang Tumor Biology 39 (10), 1010428317713390, 2017 | 31 | 2017 |
| Multi-omic molecular profiling reveals potentially targetable abnormalities shared across multiple histologies of brain metastasis K Fukumura, PB Malgulwar, GM Fischer, X Hu, X Mao, X Song, ... Acta neuropathologica 141, 303-321, 2021 | 30 | 2021 |
| Knockout of the Nogo-B gene attenuates tumor growth and metastasis in hepatocellular carcinoma B Zhu, S Chen, X Hu, X Jin, Y Le, L Cao, Z Yuan, Z Lin, S Jiang, L Sun, ... Neoplasia 19 (7), 583-593, 2017 | 30 | 2017 |
| NDRG1 in aggressive breast cancer progression and brain metastasis ES Villodre, X Hu, BL Eckhardt, R Larson, L Huo, EC Yoon, Y Gong, ... JNCI: Journal of the National Cancer Institute 114 (4), 579-591, 2022 | 29 | 2022 |
| NF90 regulates PARP1 mRNA stability in hepatocellular carcinoma D Song, H Huang, J Wang, Y Zhao, X Hu, F He, L Yu, J Wu Biochemical and biophysical research communications 488 (1), 211-217, 2017 | 27 | 2017 |
| Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion ES Villodre, X Hu, R Larson, P Finetti, K Gomez, W Balema, SR Stecklein, ... Molecular oncology 15 (10), 2752-2765, 2021 | 24 | 2021 |
| NDRG1 expression is an independent prognostic factor in inflammatory breast cancer ES Villodre, Y Gong, X Hu, L Huo, EC Yoon, NT Ueno, WA Woodward, ... Cancers 12 (12), 3711, 2020 | 23 | 2020 |
| Glaucocalyxin A inhibits the growth of liver cancer Focus and SMMC‑7721 cells L Tang, X Jin, X Hu, X Hu, Z Liu, L Yu Oncology letters 11 (2), 1173-1178, 2016 | 15 | 2016 |
| Modeling brain metastasis via tail-vein injection of inflammatory breast cancer cells X Hu, ES Villodre, WA Woodward, BG Debeb JoVE (Journal of Visualized Experiments), e62249, 2021 | 6 | 2021 |
| Abstract P3-01-10: Ndrg1-egfr axis in inflammatory breast cancer tumorigenesis and brain metastasis ES Villodre, X Hu, R Larson, BL Eckhardt, Y Gong, L Huo, J Song, ... Cancer Research 80 (4_Supplement), P3-01-10-P3-01-10, 2020 | 5 | 2020 |
| Decorin, a novel negative modulator of E-cadherin in inflammatory breast cancer X Hu, ES Villodre, R Larson, OM Rahal, X Wang, Y Gong, J Song, ... bioRxiv, 2020.07. 07.190496, 2020 | 2 | 2020 |
| Abstract GS5-08: Soluble E-cadherin: a novel prognostic biomarker and driver of brain metastasis in inflammatory breast cancer X Hu, Y Xiong, ES Villodre, J Song, GC Manyam, MJ Tacam, J Wang, ... Cancer Research 83 (5_Supplement), GS5-08-GS5-08, 2023 | 1 | 2023 |
| Abstract PO2-24-03: Soluble E-cadherin promotes inflammatory breast cancer tumorigenesis via PDIA4-mediated suppression of ferroptosis X Hu, Y Xiong, E Villodre, J Song, D Tripathy, W Woodward, ... Cancer Research 84 (9_Supplement), PO2-24-03-PO2-24-03, 2024 | | 2024 |
| Abstract PO2-14-10: A selective MCL-1 inhibitor AZD5991 showed tumor regression in a triple-negative inflammatory breast cancer xenograft model M Mughees, M Tacam, A Tan, M White, B Debeb, E Villodre, X Hu, ... Cancer Research 84 (9_Supplement), PO2-14-10-PO2-14-10, 2024 | | 2024 |
| Abstract PO2-24-06: Cancer-Associated Fibroblasts Promote Tumor Stemness in Aggressive Breast Cancers via NDRG1 E Villodre, JM Hogstrom, X Hu, N Kozlova, D Tripathy, T Muranen, ... Cancer Research 84 (9_Supplement), PO2-24-06-PO2-24-06, 2024 | | 2024 |
| Genome-wide CRISPR screen reveals the synthetic lethality between BCL2L1 inhibition and radiotherapy L Yin, X Hu, G Pei, M Tang, Y Zhou, H Zhang, M Huang, S Li, J Zhang, ... Life Science Alliance 7 (4), 2024 | | 2024 |
| Abstract P3-05-22: Serum S100A8/S100A9 levels are associated with increased risk of brain metastasis in patients with aggressive breast cancer ES Villodre, X Hu, J Song, K Gomez, X Su, J Reuben, NT Ueno, ... Cancer Research 83 (5_Supplement), P3-05-22-P3-05-22, 2023 | | 2023 |
